Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
114.49
-3.83 (-3.24%)
At close: Jul 31, 2026, 4:00 PM EDT
116.76
+2.27 (1.98%)
After-hours: Jul 31, 2026, 7:54 PM EDT

Corcept Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
111.04120.5127.67135.5566.3377.62
Short-Term Investments
197.16251.66255.67232.67365.34145.92
Cash & Short-Term Investments
308.2372.15383.33368.22431.67223.54
Cash Growth
-9.94%-2.92%4.10%-14.70%93.11%-49.28%
Accounts Receivable
76.9259.7953.9841.1231.0627.63
Other Receivables
---1414-
Total Trade Receivables
76.9259.7953.9855.1245.0627.63
Inventory
13.1912.8712.417.736.14.99
Other Current Assets
41.3740.6621.8827.5616.4210.32
Total Current Assets
439.68485.46471.6458.64499.25266.46
Net Property, Plant & Equipment
11.996.478.010.321.781.52
Long-Term Investments
236.45160.27219.8357.184.95112.28
Other Long-Term Assets
200.58184.44141.11105.3977.4543.5
Total Assets
888.7836.65840.55621.52583.43423.76

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
14.9140.4415.3817.411.986.91
Accrued Expenses
136.98124.56124.5786.9659.3740.11
Current Portion of Leases
1.921.080.830.151.140.53
Total Current Liabilities
153.8166.09140.77104.5172.4947.54
Long-Term Leases
7.55.026.11---
Other Long-Term Liabilities
21.6217.7414.0810.319.10.41
Total Long-Term Liabilities
29.1222.7620.1910.319.10.41
Total Liabilities
182.93188.85160.96114.8181.5947.95

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.140.140.140.130.130.13
Treasury Stock
-998.01-966.59-696.17-635.08-456.15-410.41
Additional Paid-in Capital
1,049968.6832.11738.52662.34591.35
Accumulated Other Comprehensive Income
0.442.26-0.220.61-0.87-0.23
Retained Earnings
654.61643.39543.74402.53296.39194.97
Shareholders' Equity
705.78647.81679.59506.71501.84375.81
Total Liabilities & Equity
888.7836.65840.55621.52583.43423.76

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
9.426.116.940.151.140.53
Net Cash (Debt)
298.78366.05376.4368.07430.53223.01
Net Cash Growth
-10.98%-2.75%2.26%-14.51%93.05%-49.10%
Net Cash Per Share
2.593.053.323.293.711.77
Book Value
705.78647.81679.59506.71501.84375.81
Book Value Per Share
6.115.405.994.534.332.98
Tangible Book Value
705.78647.81679.59506.71501.84375.81
Tangible Book Value Per Share
6.115.405.994.534.332.98
SEC Filings: 10-K · 10-Q